156 related articles for article (PubMed ID: 17198477)
1. Non-alcoholic fatty liver disease. From insulin resistance to mitochondrial dysfunction.
Solís Herruzo JA; García Ruiz I; Pérez Carreras M; Muñoz Yagüe MT
Rev Esp Enferm Dig; 2006 Nov; 98(11):844-74. PubMed ID: 17198477
[TBL] [Abstract][Full Text] [Related]
2. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities.
Sanyal AJ; Campbell-Sargent C; Mirshahi F; Rizzo WB; Contos MJ; Sterling RK; Luketic VA; Shiffman ML; Clore JN
Gastroenterology; 2001 Apr; 120(5):1183-92. PubMed ID: 11266382
[TBL] [Abstract][Full Text] [Related]
3. Fatty liver in the intensive care unit.
Paquot N; Delwaide J
Curr Opin Clin Nutr Metab Care; 2005 Mar; 8(2):183-7. PubMed ID: 15716798
[TBL] [Abstract][Full Text] [Related]
4. Role of mitochondria in non-alcoholic fatty liver disease.
Pessayre D
J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S20-7. PubMed ID: 17567459
[TBL] [Abstract][Full Text] [Related]
5. Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis.
Koliaki C; Szendroedi J; Kaul K; Jelenik T; Nowotny P; Jankowiak F; Herder C; Carstensen M; Krausch M; Knoefel WT; Schlensak M; Roden M
Cell Metab; 2015 May; 21(5):739-46. PubMed ID: 25955209
[TBL] [Abstract][Full Text] [Related]
6. [Role of oxidative stress in non-alcoholic steatohepatitis].
Mitsuyoshi H; Itoh Y; Okanoue T
Nihon Rinsho; 2006 Jun; 64(6):1077-82. PubMed ID: 16768112
[TBL] [Abstract][Full Text] [Related]
7. Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet.
Matsuzawa N; Takamura T; Kurita S; Misu H; Ota T; Ando H; Yokoyama M; Honda M; Zen Y; Nakanuma Y; Miyamoto K; Kaneko S
Hepatology; 2007 Nov; 46(5):1392-403. PubMed ID: 17929294
[TBL] [Abstract][Full Text] [Related]
8. Hepatic energy metabolism in human diabetes mellitus, obesity and non-alcoholic fatty liver disease.
Koliaki C; Roden M
Mol Cell Endocrinol; 2013 Oct; 379(1-2):35-42. PubMed ID: 23770462
[TBL] [Abstract][Full Text] [Related]
9. Hepatic lipid metabolism and non-alcoholic fatty liver disease.
Tessari P; Coracina A; Cosma A; Tiengo A
Nutr Metab Cardiovasc Dis; 2009 May; 19(4):291-302. PubMed ID: 19359149
[TBL] [Abstract][Full Text] [Related]
10. Specific Hepatic Sphingolipids Relate to Insulin Resistance, Oxidative Stress, and Inflammation in Nonalcoholic Steatohepatitis.
Apostolopoulou M; Gordillo R; Koliaki C; Gancheva S; Jelenik T; De Filippo E; Herder C; Markgraf D; Jankowiak F; Esposito I; Schlensak M; Scherer PE; Roden M
Diabetes Care; 2018 Jun; 41(6):1235-1243. PubMed ID: 29602794
[TBL] [Abstract][Full Text] [Related]
11. The role of lipid metabolism in the pathogenesis of alcoholic and nonalcoholic hepatic steatosis.
Sozio MS; Liangpunsakul S; Crabb D
Semin Liver Dis; 2010 Nov; 30(4):378-90. PubMed ID: 20960377
[TBL] [Abstract][Full Text] [Related]
12. Uncoupling protein-2 (UCP2) induces mitochondrial proton leak and increases susceptibility of non-alcoholic steatohepatitis (NASH) liver to ischaemia-reperfusion injury.
Serviddio G; Bellanti F; Tamborra R; Rollo T; Capitanio N; Romano AD; Sastre J; Vendemiale G; Altomare E
Gut; 2008 Jul; 57(7):957-65. PubMed ID: 18308829
[TBL] [Abstract][Full Text] [Related]
13. Non-alcoholic fatty liver disease pathogenesis: the present and the future.
Petta S; Muratore C; Craxì A
Dig Liver Dis; 2009 Sep; 41(9):615-25. PubMed ID: 19223251
[TBL] [Abstract][Full Text] [Related]
14. Roux-en-y gastric bypass attenuates hepatic mitochondrial dysfunction in mice with non-alcoholic steatohepatitis.
Verbeek J; Lannoo M; Pirinen E; Ryu D; Spincemaille P; Vander Elst I; Windmolders P; Thevissen K; Cammue BP; van Pelt J; Fransis S; Van Eyken P; Ceuterick-De Groote C; Van Veldhoven PP; Bedossa P; Nevens F; Auwerx J; Cassiman D
Gut; 2015 Apr; 64(4):673-83. PubMed ID: 24917551
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms of hepatic fibrosis in non-alcoholic steatohepatitis.
Rombouts K; Marra F
Dig Dis; 2010; 28(1):229-35. PubMed ID: 20460917
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial dysfunction in non-alcoholic fatty liver disease and insulin resistance: cause or consequence?
García-Ruiz C; Baulies A; Mari M; García-Rovés PM; Fernandez-Checa JC
Free Radic Res; 2013 Nov; 47(11):854-68. PubMed ID: 23915028
[TBL] [Abstract][Full Text] [Related]
17. Non-Alcoholic Fatty Liver Disease.
Engin A
Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211
[TBL] [Abstract][Full Text] [Related]
18. The role of oxidative stress in non-alcoholic steatohepatitis.
Koek GH; Liedorp PR; Bast A
Clin Chim Acta; 2011 Jul; 412(15-16):1297-305. PubMed ID: 21514287
[TBL] [Abstract][Full Text] [Related]
19. Role of insulin resistance and lipotoxicity in non-alcoholic steatohepatitis.
Cusi K
Clin Liver Dis; 2009 Nov; 13(4):545-63. PubMed ID: 19818304
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial glutathione: hepatocellular survival-death switch.
Garcia-Ruiz C; Fernandez-Checa JC
J Gastroenterol Hepatol; 2006 Oct; 21 Suppl 3():S3-6. PubMed ID: 16958667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
